Explaining the absence of surgical procedure regulation

Area of Science:

• Medical Regulation
• Surgical Innovation
• Evidence-Based Medicine

Background:

• Approximately 64 million surgical procedures are performed annually in the U.S. without direct federal approval or regulation.
• Unlike pharmaceuticals, surgical procedures are not systematically reviewed for safety and efficacy by agencies like the Food and Drug Administration (FDA).
• Current methods of surgical knowledge transfer, primarily didactic, result in significant regional variations in techniques and unclear outcome data.

Purpose of the Study:

• To examine the existing indirect regulatory framework for surgical procedures.
• To explore reasons behind the lack of direct federal regulation for surgical procedures.
• To consider the potential benefits of increased surgical regulation on evidence generation and clinical practice.

Main Methods:

• Review of the current indirect regulatory landscape for surgical procedures.
• Analysis of justifications for the absence of direct federal regulation.
• Exploration of potential impacts of enhanced regulation on evidence identification, data collection, and clinical decision-making.

Main Results:

• The U.S. lacks a formal approval process for new surgical procedures, contrasting with pharmaceutical regulation.
• Variations in surgical techniques are common due to the didactic transfer of knowledge, leading to inconsistent evidence.
• Arguments against regulation include concerns about self-regulation, deterring beneficial innovation, and disrupting the doctor-patient relationship.

Conclusions:

• The absence of direct regulation impacts the quality of evidence supporting surgical choices.
• Increased regulation could help identify and fill critical evidence gaps for both innovative and standard procedures.
• Enhanced regulation may positively influence surgeon decision-making and improve the informed consent process for patients.